Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...
Frontstretch1h
Here Are the 2025 Darlington Throwback Paint Schemes
2025 marks 75 years of historic moments at @TooToughToTame, and we're thrilled to be honoring one of them by celebrating the ...